Position in ZTS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$19,572,029
+$1,720,310 QoQ
Shares Held
165,570
+16.7% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pacer Advisors, Inc. holds $370,550,834 across 18 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
243,545 | $144,417,314 | |
| 2 | VTRS |
Viatris Inc
|
8,033,876 | $108,537,664 | |
| 3 | ALKS |
Alkermes plc.
|
688,563 | $24,347,587 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
169,230 | $22,294,360 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
165,570 | $19,572,029 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,563,040 | $14,880,140 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
256,365 | $8,477,990 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
85,467 | $6,572,412 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,572,029 | 165,570 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $17,851,719 | 141,883 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $17,546,548 | 119,919 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $21,772,959 | 139,615 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,881,634 | 60,016 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,537,694 | 52,401 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $9,106,857 | 46,611 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,999,236 | 40,374 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,161,243 | 30,502 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,088,740 | 35,916 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $6,839,675 | 39,313 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,592,026 | 38,279 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $5,714,550 | 34,334 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $241,074 | 1,645 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $681,392 | 4,595 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $752,706 | 4,379 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,581,794 | 24,295 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $7,487,816 | 30,684 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $8,280,847 | 42,654 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $6,660,506 | 35,740 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $4,103,771 | 26,059 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $4,931,734 | 29,799 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $6,168,631 | 37,302 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $6,000,570 | 43,787 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||